等待开盘 08-15 09:30:00 美东时间
+0.115
+0.31%
IO Biotech announced topline results from a pivotal Phase 3 trial of its investigational cancer vaccine Cylembio in combination with pembrolizumab for the treatment of advanced melanoma. The trial showed an improvement in progression-free survival (PFS) for patients treated with Cylembio plus pembrolizumab compared to pembrolizumab alone (median PFS 19.4 months vs. 11.0 months), though statistical significance on the primary endpoint was narrowly...
08-11 12:00
In the financial world's ongoing tug-of-war for the ultimate risk management strategy, a captivating debate has taken center stage: Is Bitcoin (CRYPTO: BTC) or gold the superior choice as a hedge in the face of mounting concerns over rising interest rates and the looming
2023-08-10 20:00
美联储周三如预期宣布加息25个基点,将联邦基金利率区间上调为0.25%-0.50%;在加息环境下,分析师看好这些ETF将有不错表现 >>
2022-03-17 21:00